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Melittin (ME), a non-cell-selective antimicrobial peptide, contains the leucine zipper motif, wherein every seventh amino acid is leucine or
isolucine. Here, we attempted to generate novel cell-selective peptides by substituting amino acids in the leucine zipper sequence of ME with
peptoid residues. We generated a series of ME analogues by replacing Leu-6, Lue-13 and Ile-20 with Nala, Nleu, Nphe, or Nlys, and we examined
their secondary structure, self-association activity, cell selectivity and mode of action. Circular dichroism spectroscopy indicated that the
substitutions disrupt the α-helical structure of ME in micelles of sodium dodecyl sulfate and on negatively charged and zwitterionic phospholipid
vesicles. Substitution by Nleu, Nphe, or Nlys but not Nala disturbed the self-association in an aqueous environment, interaction with zwitterionic
membranes, and toxicity to mammalian cells of ME but did not affect the interaction with negatively charged membranes or antibacterial activity.
Notably, peptides with Nphe or Nlys substitution had the highest therapeutic indices, consistent with their lipid selectivity. In addition, all of
peptoid residue-containing ME analogues had little or no ability to induce membrane disruption, membrane depolarization and lipid flip-flop.
Taken together, our studies indicate that substitution of the leucine zipper motif in ME with peptoid residues increases its selectivity against
bacterial cells by impairing self-association activity and changes its mode of antibacterial action from membrane-targeting mechanism to possible
intracellular targeting mechanism. Furthermore, our ME analogues especially those with Nleu, Nphe, or Nlys substitutions, may be therapeutically
useful antimicrobial peptides.
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vesicles; MALDI-TOF MS, matrix-assisted laser-desorption ionization-time-of-
flight mass spectrometry; MIC, minimal inhibitory concentration; MTT, 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide; PBS, phosphate-
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Antimicrobial peptides (AMPs) are important and effective
components in innate host defenses against infectious patho-
gens [1–3]. Most AMPs do not target specific receptors of the
pathogens but instead interact and permeabilize microbial
membranes [4]. Recently, AMPs have been tapped as a new
source of potential antibiotics to combat the increasing
emergence of drug-resistant bacteria [5]. AMPs are generally
12 to 50 amino acids in length. In spite of the diversity of their
amino acid sequences, most of these peptides have a high net
positive charge and an amphipathic secondary structure such as
α-helical and β-sheet structure in lipid membrane conditions
Fig. 1. Helical wheel projections of melittin (A) and its peptoid residue-containing analogues, ME-X, where X corresponds to the peptoid residues (B).
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of their cell selectivity: those that are toxic for bacterial cells but
not mammalian cells (e.g. magainins and cecropins), and those
that are toxic to both bacterial and mammalian cells (e.g.
melittin (ME) and pardaxin).
The length, charge, overall hydrophobicity, α-helicity and
amphipathic character of AMPs are reported to be responsible
for their selectivity for bacterial and mammalian cells [8,9]. In
addition to these parameters, the self-association of AMPs in
an aqueous environment is also known to be important for
controlling their selectivity for specific targets [10–13].
Studies of the frog skin-derived AMP dermaseptin-4 [14],
the cathelicidin-derived AMP LL-37 and its N-terminal
truncated peptide [15] and the model AMPs [16] have
revealed that peptides with higher abilities to self-associate
in an aqueous environment are also more toxic to mammalian
cells.
Recently, Ghosh et al. identified a leucine zipper motif in ME
that seems to play a prominent role in conferring toxicity to
mammalian cells but not in its antibacterial activity [17].
Substitution of heptadic leucine in ME by alanine caused a
significant disruption in the α-helical structure in an aqueous
environment and in the presence of zwitterionic lipid vesicles
but not in the presence of negatively charged vesicles. These
results suggested that the α-helical assembly or peptide–peptide
interaction in ME is important for its ability to interact with
zwitterionic membrane and cause hemolysis.Table 1
Amino acid sequences, calculated and observed molecular masses, net charges, and
Peptide
designation
Amino acid sequences a
ME GIGAVLKVLTTGLPALISWIKRKRQQ-NH2
ME-a GIGAVaKVLTTGaPALISWaKRKRQQ-NH2
ME-l GIGAVlKVLTTGlPALISWlKRKRQQ-NH2
ME-f GIGAVfKVLTTGfPALISWfKRKRQQ-NH2
ME-k GIGAVkKVLTTGkPALISWkKRKRQQ-NH2
a a: Nala [CH3-NH-CH2-COOH)], l: Nleu [(CH3)2-CH-NH-CH2-COOH)], f: Nph
b Molecular mass were determined by MALDI-TOF-MS.
c Retention time was measured using a C18 reverse-phase analytical column (5 μm
gradient of 5% to 60% acetonitrile in water containing 0.05% (v/v) trifluoroacetic aThe presence of proline in α-helices generally creates a bend
or kink in the peptide backbone because of the lack of amide
proton, which normally provides the hydrogen donor in α-
helical structure. Some studies have suggested that the partial
disruption of α-helical structure of non-cell-selective α-helical
native or model AMPs by the insertion or substitution of proline
is useful for developing novel antibiotic AMPs that have little or
no hemolytic activity [18–21].
Like proline, peptoid residues are imino acids because their
side chains are shifted from the α-carbon to the N-position. Also
like proline, peptoid residues are thought to have a general
helix-breaking tendency due to the lack of an amide proton
[22,23]. In a recent study, we showed that the incorporation of
two alanine peptoid residues into the hydrophobic face of a non-
cell-selective α-helical antimicrobial model peptide signifi-
cantly reduces the hemolytic activity but not the antibacterial
activity [24].
Therefore, in this study, to develop cell-selective ME
analogues, we synthesized a series of four ME analogues in
which key leucine zipper residues (Leu-6, Lue-13, and Ile-20)
were replaced with peptoid residues CH3–NH–CH2–COOH
(Nala), (CH3)2–CH–NH–CH2–COOH (Nleu), H5C6–CH2–
NH–CH2–COOH (Nphe), or NH2–(CH2)4–NH–CH2–COOH
(Nlys) (Fig. 1 and Table 1). We investigated their antimicrobial
activities against Gram-positive and Gram-negative bacterial
strains including antibiotic-resistant clinical isolates as well as
their abilities to cause hemolysis. In addition, to examine theRP-HPLC retention times of the peptides
Molecular mass (Da) Net
charge
Retention c
time (min)
Calculated Observed b
2846.5 2846.4 +6 38.33
2720.2 2720.3 +6 26.60
2846.5 2846.9 +6 31.72
2948.5 2948.5 +6 32.95
2891.5 2892.5 +9 23.37
e [H5C6-CH2-NH-CH2-COOH)], k: Nlys [NH2-(CH2)4-NH-CH2-COOH].
; 4.6×250 mm; Vydac). The peptides were eluted over 40 min, using a linear
cid.
1508 W.L. Zhu et al. / Biochimica et Biophysica Acta 1768 (2007) 1506–1517molecular basis of their cell selectivity, we examined the
secondary structures of these peptides in different environments
by circular dichroism (CD) spectroscopy and examined their
interaction with model phospholipid membranes by measuring
tryptophan fluorescence. Furthermore, we examined their
abilities to permeabilize model liposomes, depolarize mem-
branes of intact Staphylococcus aureus and induce flip-flop of
model membranes.
2. Materials and methods
2.1. Materials
Rink amide 4-methylbenzhydrylamine resin, fluoren-9-yl-methoxycarbonyl
(Fmoc)-amino acids and other reagents for the peptide synthesis were purchased
from Calibochem-Novabiochem (La Jolla, CA). Egg yolk L-α-phosphatidylcho-
line (EYPC), egg yolk L-α-phosphatidylethanolamine (EYPE), egg yolk L-α-
phosphatidyl-DL-glycerol (EYPG), acrylamide, calcein, 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT), EDTA, HEPES, SDS and
gramicidin D were supplied from Sigma Chemical Co. (St. Louis, MO). 3,3′-
dipropylthiadicarbocyanine iodide (DiSC3-5) was obtained from Molecular
Probes (Eugene, OR). 1-palmitoyl-2-[6-[7-nitrobenz-2-oxa-1,3-diazol-4-yl]
amino] capryl]-L-α-phosphatidylethanolamine (C6-NBD-PE) was purchased
from Avanti Polar Lipids (Alabaster, AL). DMEM and fetal bovine serum (FBS)
were supplied from HyClone (SeouLin, Bioscience, Korea). Human cervical
carcinoma HeLa and mouse fibroblastic NIH-3T3 cells were procured from the
American Type Culture Collection (Manassas, VA). All other reagents were of
analytical grade. The buffers were prepared in double glass-distilled water.
2.2. Peptide synthesis
The peptides used in this study were prepared by the standard Fmoc-based
solid-phase method on rink amide MBHA resin (0.54 mmol/g). Fmoc-Nleu-OH,
Fmoc-Nphe-OH and Fmoc-Nlys-OH were synthesized using the previous
methods [22,23]. DCC (dicyclohexylcarbodiimide) and HOBt (N-hydroxyben-
zotriazole) were used as coupling reagent, and ten-fold excess Fmoc-amino
acids were added during every coupling cycle. After cleavage and deprotection
with a mixture of trifluoroacetic acid/water/thioanisole/ethanedithiol/triisopro-
pylsilane (81.5:5:5:5:2.5:1, v/v) for 2 h at room temperature, the crude peptides
were repeatedly extracted with diethyl ether and purified by reverse phase HPLC
on a preparative Vydac C18 column (15 μm, 20×250 mm) using an appropriate
0–80% water/acetonitrile gradient in the presence of 0.05% trifluoroacetic acid.
The final purity of the peptides (>98%) was assessed by reverse phase HPLC on
an analytical Vydac C18 column (5 μm, 4.6×250 mm) and their identities were
confirmed by MALDI-TOF MS (matrix-assisted laser-desorption ionization-
time-of-flight mass spectrometry) (Shimadzu, Japan) (Table 1).
2.3. Antimicrobial activity (MIC)
The antibacterial activities of the peptides against three Gram-positive
bacterial strains, three Gram-negative bacterial strains and four antibiotic-
resistant clinical isolates were examined in sterile 96-well plates using the broth
microdilution method as previous reports. Aliquots (100 μl) of a bacterial
suspension at 2×106 colony-forming units (CFU)/ml in 1% peptone were added
to 100 μl of peptide solution (serial 2-fold dilutions in 1% peptone). After
incubation for 18–20 h at 37 °C, the inhibition of bacterial growth was
determined by measuring the absorbance at 620 nm with a Microplate
autoreader EL 800 (Bio-Tek Instruments). The minimal inhibitory concentration
(MIC) is defined as the minimal peptide concentration that inhibits bacteria
growth. Three types of Gram-positive bacteria (Bacillus subtilis [KCTC 3068],
Staphylococcus epidermidis [KCTC 1917] and S. aureus [KCTC 1621]) and
three types of Gram-negative bacteria (Escherichia coli [KCTC 1682], Pseu-
domonas aeruginosa [KCTC 1637] and Salmonella typhimurium [KCTC
1926]) were procured from the Korean Collection for Type Cultures (KCTC) at
the Korea Research Institute of Bioscience and Biotechnology. Methicillin-
resistant S. aureus (MRSA) (CCARM 3001 and CCARM 3543) and multidrug-resistant P. aeruginosa (MDRPA) (CCARM 2095 and CCARM 2109) were
obtained from the Culture Collection of Antibiotic-Resistant Microbes
(CCARM) at Seoul Women's University in Korea.
2.4. Hemolytic activity (MHC)
Fresh human red blood cells (hRBCs) were washed 3 times with PBS
(35 mM phosphate buffer, 0.15 M NaCl, pH 7.4) by centrifugation for 7 min at
1000×g and resuspended in PBS. The peptide solutions (serial 2-fold dilutions in
PBS) were added to 100 μl suspension of hRBCs (4% (v/v) in final) in PBS to
the final volume of 200 μl and were incubated for 1 h at 37 °C. The samples were
then centrifuged at 1000×g for 5 min, and the release of hemoglobin was
monitored by measuring the absorbance of the supernatant at 405 nm by
Microplate ELISA Reader. The MHC is defined as the minimal peptide
concentration that produces hemolysis. For negative and positive controls,
hRBCs in PBS (Ablank) and in 0.1% Triton X-100 (Atriton) were used,
respectively. The percentage of hemolysis was calculated according to the
equation:
% hemolysis ¼ 100 ½ðAsample  AblankÞ=ðAtriton  AblankÞ
2.5. Cytotoxicity against mammalian cells
Human cervical carcinoma HeLa and mouse fibroblastic NIH-3T3 cells
were cultured in DMEM with 10% FBS. The cells were maintained under 5%
CO2 at 37 °C. Cytotoxicity of the peptides against mammalian cells was
determined by MTTassay as previously reported [25] with minor modifications.
The cells were seeded on 96 well microplates at a density of 2×104 cells/well in
150 μl of DMEM containing 10% FBS. The plates were then incubated for 24 h
at 37 °C in 5% CO2 atmosphere. 20 μl of peptide solution (serial 2 fold dilutions
in DMEM) were added and the plates were further incubated for 2 days. Wells
containing cells without peptides served as controls. Subsequently, 20 μl of
MTT solution (5 mg/ml) was added to each well, and the plates were further
incubated for 4 h at 37 °C. The precipitated MTT formazan was dissolved in
40 μl of 20% (w/v) SDS containing 0.01 M HCl overnight. The absorbance at
570 nm was measured using a microplate ELISA reader (Molecular Devices,
Sunnyvale, CA). Percent cell survival was expressed as a percent ratio of A570 of
cells treated with peptide over cells only.
2.6. Circular dichroism (CD) measurement
The CD spectra of peptides were recorded in the sodium phosphate buffer
(pH 7.4), sodium phosphate buffer containing 1.5 M NaCl and sodium
phosphate buffer with 30 mM SDS or in the presence of different SUVs by
utilizing a Jasco J 715 CD spectrophotometer (Tokyo, Japan). The samples were
scanned in a capped quartz cuvette of 1 mm path length in the wavelength range
of 250–190 nm at 20 °C under nitrogen flush. The concentration of peptides in
sodium phosphate buffer containing 1.5 M NaCl was from 20 μM to 100 μM.
2.7. Preparation of small unilamellar vesicles (SUVs)
Small unilamellar vesicles were prepared by a standard procedure with
required amounts of either EYPE/EYPG (7:3, w/w) or EYPC/cholesterol (10:1,
w/w) for tryptophan fluorescence. Dry lipids were dissolved in chloroform in
small glass vessel. Solvents were removed by rotary evaporation to form a thin
film on the wall of a glass vessel and then lyophilized overnight. Dried thin films
were resuspended in Tris–HCl buffer by vortex mixing. The lipid dispersions
were then sonicated in ice water for 10–20 min with a titanium-tip ultrasonicator
until the solution became transparent.
2.8. Tryptophan fluorescence blue shift
The fluorescence emission spectrum of tryptophan of peptides was
monitored in aqueous Tris–HCl buffer, Tris–HCl buffer containing 1.5 M
NaCl and in the presence of vesicles composed of either EYPE/EYPG (7:3 w/w)
SUVs or EYPC/cholesterol (10:1 w/w) SUVs. In these fluorometric studies,
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scattering effects [26,27]. The tryptophan fluorescence measurements were
taken with a model RF-5301PC spectrophotometer (Shimadzu, Japan). Each
peptide was added to 3 ml of Tris–HCl buffer (10 mM Tris, 0.1 mM EDTA,
150 mM NaCl, pH 7.4) containing 0.6 mM liposomes (pH 7.4), and the peptide/
liposome mixture (a molar ratio of 1:200) was allowed to interact at 20 °C for
10 min. The fluorescence was excited at 280 nm, and the emission was scanned
from 300 to 400 nm.
2.9. Quenching of Trp emission by acrylamide
For fluorescence quenching experiment, acrylamide was used as the
quencher and the fluorescence measurements were taken with a model RF-
5301PC spectrophotometer. To reduce absorbance by acrylamide, excitation of
Trp at 295 nm instead of 280 nm was used [28,29]. Aliquots of the 3.0 M
solution of this water-soluble quencher were added to the peptide in the presence
of 0.6 mM liposome at a peptide/lipid molar ratio of 1:200. The effect of
acrylamide on the fluorescence of each peptide was analyzed by a Stern-Volmer
equation: F0 /F=1+Ksv [Q], where F0 and F represent the fluorescence
intensities in the absence and the presence of acrylamide, respectively, and Ksv is
the Stern–Volmer quenching constant and [Q] is the concentration of
acrylamide.
2.10. Dye leakage
Calcein-entrapped LUVs composed of EYPE/EYPG (7:3, w/w) were
prepared by vortexing the dried lipid in dye buffer solution (70 mM calcein,
10 mM Tris, 150 mM NaCl, 0.1 mM EDTA, pH 7.4). The suspension was
frozen–thawed in liquid nitrogen for ten cycles and extruded 21 times through
polycarbonate filters (two stacked 100 nm pore size filters) by a LiposoFast
extruder (Avestin, Inc. Canada). Untrapped calcein was removed by gel filtration
on a Sephadex G-50 column. The Calcein-entrapped LUVs concentration was
determined in triplicate by phosphorus analysis [30]. The leakage of calcein
from the LUVs was monitored by measuring fluorescence intensity at an
excitation wavelength of 490 nm and an emission wavelength of 520 nm on a
model RF-5301PC spectrophotometer. For determination of 100% dye-release,
20 μl 10% Triton-X100 in Tris-buffer was added to dissolve the vesicles. The
percentage of dye-leakage caused by the peptides was calculated as follows:
% Dye leakage ¼ 100 ½ðF  F0Þ=ðFt  F0Þ
where F is the fluorescence intensity achieved at 5 min after addition of
peptides, F0 and Ft are fluorescence intensities without the peptides and with
Triton X-100, respectively.
2.11. Membrane depolarization
The membrane depolarization activity of peptides was determined using
intact S. aureus cells and the membrane potential-sensitive fluorescent dye,
DiSC3-5 based on the methods of Friedrich et al. [31,32]. Briefly, S. aureus was
grown at 37 °C with agitation to mid-log phase (OD600=0.4) were harvest by
centrifuge. The cells were washed twice with washing buffer (20 mM glucose,
5 mM HEPES, pH 7.4) and resuspended to an OD600 of 0.05 in a similar buffer
containing 0.1 M KCl. Following, the cells were incubated with 20 nM DiSC3-5
until a stable reduction of fluorescence was achieved, indicating the
incorporation of the dye into the bacterial membrane. Membrane depolarization
was then monitored by observing the change in the intensity of fluorescence
emission of the membrane potential-sensitive dye DiSC3-5 (λex=622 nm, λem=
670 nm) after the addition of peptides. Full dissipation of the membrane
potential was obtained by adding gramicidin D (final concentration, 0.2 nM).
The membrane potential-dissipating activity of the peptides is expressed as
follows:
% Membrane depolarization ¼ 100 ½ðFp  F0Þ=ðFg  F0Þ
where F0 is the stable fluorescence value after addition of the DiSC3-5 dye, Fp is
the fluorescence value 5 min after addition of the peptides, and Fg the
fluorescence signal after the addition of gramicidin D.2.12. Lipid flip-flop
The peptide-induced flip-flop of lipid was detected as previously reported
[33–35]. NBD-labeled LUVs composed of EYPE/EYPG (7:3, w/w) contain-
ing 0.5 mol% C6-NBD-PE were prepared by vortexing the dried lipid in Tris–
HCl buffer. The suspension was frozen–thawed in liquid nitrogen for ten
cycles and extruded 21 times through polycarbonate filters (two stacked
100 nm pore size filters) by a LiposoFast extruder. For inner-leaflet
exclusively labeled liposomes, the symmetrically labeled liposomes were
mixed with 1 M sodium dithionite/1 M Tris–HCl ([lipid]=0.1 mM;
[dithionite]=5 mM) and incubated for 15 min at 30 °C. The NBD groups
in the outer leaflet of the bilayers were chemically quenched by the water-
soluble dithionite. The liposomes were immediately separated from dithionite
by gel filtration using Sephadex G-50 column at 4 °C. 3 mL of 0.1 mM
asymmetrically NBD-labeled LUVs were incubated with peptides in different
concentrations at 30 °C. Then 30 μl of a trypsin solution (5 mg/mL) were
added, and the solution was reacted for 2 min in order to hydrolyze the
inactivate peptide because every peptide contains three lysine residues. After
30 μl of 1 M dithionite solution have been added, the extent of peptide-
mediated lipid flip-flop was indicated by the percentage of the NBD groups
being transposed from the inner leaflet to the outer leaflet where they would
then be quenched by dithionite. The peptide-induced flip-flop of the
fluorescent lipid was thus recorded as a decrease of fluorescence intensity
of the NBD group on a model RF-5301PC spectrophotometer. Excitation and
emission wavelength of NBD fluorescence was 460 nm and 530 nm,
respectively. The percent flip-flop value was defined by the following
equation:
% flip flop ¼ 100 ½ðF0  FpÞ=ðF0  FtÞ
where F0, Fp, and Ft represent the fluorescence intensity in asymmetrically
labeled liposomes without the peptide, achieved at 5 min after addition of
peptides, and with Triton X-100, respectively.
3. Results
3.1. Peptide design
As shown in Fig. 1 and Table 1, ME contains a leucine
zipper motif, in which every seventh amino acid is leucine or
isolucine (Leu-6, Leu-13, and Ile-20 at the ‘a’ position and
Ile-2, Leu-9 and Leu-16 at the ‘d’ position). To develop
novel cell-selective ME analogues containing peptoid resi-
dues and to determine their mechanism of antibacterial
action, we synthesized four analogues in which Leu-6, Lue-
13, and Ile-20 were replaced by Nala, Nleu, Nphe, or Nlys,
which are the peptoid versions of Ala, Leu, Phe and Lys,
respectively.
3.2. Hydrophobicity and cationicity of the peptides
The relative hydrophobicity of ME analogues containing
peptoid residues was determined by measuring their retention
time during reversed-phase high-performance liquid chromato-
graphy (RP-HPLC) (Table 1) [36,37]. The relative hydropho-
bicity of ME and its derivative peptides decreased in the
following order: ME>ME-f>ME-l>ME-a>ME-k. This is
consistent with the relative hydrophobicities of the peptoid
residue [22]. In addition, ME-a, ME-l and ME-f possess six net
positive charges like native ME, whereas ME-k has nine
positive charges because of the substitution of three Nlys
residues (Table 1).
1510 W.L. Zhu et al. / Biochimica et Biophysica Acta 1768 (2007) 1506–15173.3. CD spectroscopy
CD spectroscopy was used to study the secondary structures
of the peptides in various conditions. In the aqueous environ-
ment, all of the peptides displayed a negative band at around
200 nm, suggesting a random structure. In the presence of
30 mM SDS, 1 mM EYPE/EYPG (7:3, w/w) SUVs or 1 mM
EYPC/cholesterol (10:1, w/w) SUVs, ME showed two negative
bands at 208 nm and 222 nm, suggesting a well defined α-
helical conformation. In contrast, ME-a, ME-l, ME-f, and ME-k
each displayed a single negative band at around 200 nm,
suggesting a random structure in various conditions of 30 mM
SDS micelles, 1 mM EYPE/EYPG (7:3, w/w) SUVs, or 1 mM
EYPC/cholesterol (10:1, w/w) SUVs (Fig. 2). The CD data
revealed that the substitution of peptoid residues with Leu6,
Lue13 and Ile20, which correspond to the “a” positions of the
leucine zipper sequence in ME, completely disrupts the α-
helical conformation, resulting in a random structure.
3.4. Self-association
It has been reported that ME self-associates into a tetrameric
helical structure in an aqueous environment at high ionic
strength. This self-association activity is thought to be related to
its high toxicity to mammalian cells [17,38–42]. Therefore, we
used CD spectroscopy and measured tryptophan fluorescence
under conditions of high ionic strength to determine how the
peptoid residue substitutions in the leucine zipper motif affect
the self-association of ME. The mean residue ellipticity values
at 222 nm of the peptides in phosphate-buffered saline
containing 1.5 M NaCl is shown in Fig. 3A. ME showed aFig. 2. The CD spectra of 50 μM peptides in 10 mM sodium phosphate buffer (pH 7.4
presence of 1 mM EYPE/EYPG (7:3, w/w) SUVs (C) or 1 mM EYPC/cholesterol (1
indicated as follows: ME (●), ME-a (○), ME-l (▾), ME-f (▽), ME-k (▪).concentration-dependent formation of an α-helical conforma-
tion (data not shown) and a large increase on the mean residue
ellipticity value ([θ]) at 222 nm (Fig. 3A) as described in our
previous report [42], indicating formation of self-association
helices. In contrast, the peptoid residue-containing analogues
showed little or no of an increase on [θ] at 222 nm. Additionally,
we observed a blue shift in the emission maximum of
tryptophan from 350 to 340 nm for ME in Tris–HCl buffer
containing 1.5 M NaCl, but a blue shift was not observed for the
peptoid residue-containing analogues (Fig. 3B). Both the CD
spectra and the tryptophan fluorescence data at high ionic
strength indicated that incorporation of peptoid residues into the
leucine zipper motif of ME disrupt its ability to self-associate.
3.5. Antimicrobial activity
To provide an overall measure of antimicrobial activity, we
calculated the geometric mean (GM) of the minimal peptide
concentration that inhibits bacteria growth (MIC) [10] in six
selected bacterial strains (Table 2). Compare to native ME, all of
the peptoid residue-containing analogues had 2- to 10-fold
lower antimicrobial activity. The order of potency for the
peptides was ME>ME-f>ME-l>ME-a, which is consistent
with their hydrophobicities (Table 1). Notably, ME-f and ME-k
had the same antibacterial activity against bacterial strains but 2-
fold lower activities than native ME (Table 2).
3.6. Hemolytic activity
As expected, ME caused very strong hemolysis of hRBCs
and was hemolytic at a very low concentration (0.78 μM)) (A), 10 mM sodium phosphate buffer (pH 7.4) with 30 mM SDS (B), and in the
0:1, w/w) SUVs (D) in 10 mM sodium phosphate buffer (pH 7.4). Peptides are
Fig. 3. Plots of mean residue ellipticity ([θ]) at 222 nm vs. peptide
concentration in phosphate-buffered saline containing 1.5 M NaCl (A).
Fluorescence spectra of 3 μM peptides in Tris–HCl buffer containing 1.5 M
NaCl (B). Peptides are indicated as follows: ME (●), ME-a (○), ME-l (▾),
ME-f (▽), ME-k (▪).
Fig. 4. Dose–response of the hemolytic activity of the peptides toward human
erythrocytes. Values are the means of two independent experiments performed
in duplicate±S.D. values (error bars). Peptides are indicated as follows: ME (●),
ME-a (○), ME-l (▾), ME-f (▽), ME-k (▪).
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containing analogues caused hemolysis, even at concentra-
tions as high as 100 μM (Table 2 and Fig. 4).Table 2
Antimicrobial and hemolytic activities of the peptides against bacterial strains and h
Peptide MIC a (μM)
E. coli P. aeruginosa S. typhimurium B. subtilis S. epide
ME 2 2 2 1 1
ME-a 16 8 32 4 32
ME-l 4 4 16 1 4
Me-f 4 4 8 1 2
Me-k 4 4 4 2 2
a MIC were determined in three independent experiments performed in triplicate
b The geometric mean (GM) of the MIC values from all six bacterial strains in th
c The minimal peptide concentration that produces hemolysis. When no detectable
therapeutic index.
d The ratio of the MHC (μM) over the geometric mean (GM) of the MIC (μM). L
e The fold improvement in therapeutic index compared with the parent peptide (M3.7. Cell selectivity/therapeutic index
To assess the cell selectivity of our peptides, we calculated
their therapeutic index, which is a widely accepted measure of
the cell selectivity of antimicrobial agents. The therapeutic
index was calculated as the ratio of the minimal peptide
concentration that produces hemolysis (MHC) to the MIC. A
larger therapeutic index indicates greater cell selectivity [10].
The therapeutic index of ME was 0.6, which is consistent with
its poor cell selectivity (Table 2). On the other hand, the peptoid
residue-containing ME analogues had therapeutic indices
between 14.0 and 71.4, although they have lower antimicrobial
activity than ME. ME-f and ME-k had the highest therapeutic
indices (119.0-fold increase compared to ME).
3.8. Activity against antibiotic-resistant clinical isolates
We next measured the antimicrobial activities of the peptoid
residue-containing ME analogues against antibiotic-resistant
clinical isolates to assess their potential usefulness as therapeu-
tic agents. As seen in Table 3, all of ME analogues were
effective at killing two methicillin-resistant S. aureus strains
and two multidrug-resistant P. aeruginosa trains. Noticeably,uman red blood cells
GMb
(μM)
MHCc
(μM)
Therapeutic Index d
(MHC/GM)
Fold e
rmidis S. aureus
0.5 1.3 0.78 0.6 1.0
16 14.3 >100 14.0 23.3
4 4.0 >100 50.0 83.3
2 2.8 >100 71.4 119.0
2 2.8 >100 71.4 119.0
with a standard deviation of 14.0%.
is table.
hemolysis was observed at 100 μM, we used a value of 200 μM to calculate the
arger values indicate greater cell selectivity.
E).
Table 3
MIC of the peptides against antibiotic-resistant clinical isolates
Peptides MIC (μM) a
MRSA 1b
(CCARM
3001)
MRSA 2
(CCARM
3543)
MDRPA 1 c
(CCARM
2095)
MDRPA 2
(CCARM
2109)
ME 1 1 8 8
ME-a 64 32 32 16
ME-l 8 8 4 4
ME-f 4 4 8 8
ME-k 8 2 8 8
a Determined in three independent experiments performed in triplicate with a
standard deviation of 11.4%.
b Methicillin-resistant Staphylococcus aureus strain.
c Multidrug-resistant Pseudomonas aeruginosa strain.
Table 4
Tryptophan emission maxima of 3 μM peptides and Ksv in Tris-buffer (pH 7.4)
or in the presence of 0.6 mMEYPE/EYPG (7:3, w/w) SUVs and 0.6 mMEYPC/
cholesterol (10: 1, w/w) SUVs
Peptide Tris-buffer
(nm)
EYPE/
EYPG
(7:3, w/w)
(nm)
EYPC/
cholesterol
(10:1, w/w)
(nm)
Ksv (M
−1) a
Tris-
buffer
EYPE/
EYPG
(7:3,
w/w)
EYPC/
cholesterol
(10:1, w/w)
ME 350 333 (−17) b 336 (−14) 3.70 1.20 1.50
ME-a 350 347 (−3) 350 (0) 3.45 2.98 2.74
ME-l 350 336 (−14) 350 (0) 4.43 1.72 3.16
ME-f 350 336 (−14) 350 (0) 4.13 1.28 3.23
ME-k 350 342 (−8) 350 (0) 3.53 1.28 2.93
a Ksv is the Stern–Volmer quenching constant.
b Blue shift in emission maximum in parentheses.
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and 8 μM.
3.9. Toxicity to mammalian cells
To further investigate the cytotoxicity of peptides against
mammalian cells, we examined their abilities to inhibit the
growth of two mammalian cell lines, human cervical carcinoma
HeLa and mouse fibroblastic NIH-3T3 cells. The effects on cell
growth were assessed bymeasuringmitochondrial conversion of
MTT to a colored product (Fig. 5). The dose–response curves for
the peptides showed that ME can completely inhibit the growth
of the two mammalian cell lines at ∼ 10 μM, but ME-a, ME-l,
and ME-k did not exhibit any cytotoxicity toward the two
mammalian lines even at 100 μM. ME-f was also not toxic to
NIH 3T3 cells at 100 μM, but it caused ∼ 20% inhibition of
HeLa cell growth at 100 μM. It is noteworthy that ME-f was not
toxic to HeLa cells at its MICs (1–8 μM) (Table 2 and Fig. 5).
Thus, all of the peptoid residue-containing analogues could be
useful antibiotic agents.
3.10. Tryptophan fluorescence blue shift and quenching by
acrylamide in model membranes
The present of a tryptophan at residue 19 of each peptide
allowed us to monitor the binding of the peptides to liposome byFig. 5. Cytotoxicity of the peptides against NIH 3T3 cells (A) and HeLa cells (B). Va
values (error bars). Peptides are indicated as follows: ME (●), ME-a (○), ME-l (▾the fluorescence emission of the tryptophan. All of the peptides
had a fluorescence emission maximum at 350 nm in buffer,
which is typical for Trp in a water-polar environment. In
negatively charged phospholipids [EYPE/EYPG (7:3, w/w)
SUVs], which mimic bacterial membranes, the fluorescence
emission maxima of all the peptides except for ME-a exhibited a
big blue shift, indicating these peptides penetrates into the
hydrocarbon region of the bilayer. In zwitterionic phospholipids
membranes [EYPC/cholesterol (10:1, w/w) SUVs], which
mimic the outer surface of mammalian membranes, ME-a,
ME-l, ME-k and ME-f did not exhibit a blue shift in the
fluorescence emission maxima like they were in buffer, ME in
contrast, still exhibited a blue shift (14 nm). These results
suggest that the tryptophan residue of ME but not of the other
peptides was inserted into the hydrophobic lipid phase of the
bilayer in the zwitterionic phospholipids (Table 4).
To further investigate the relative extent of peptide burial in
liposomes and the lipid specificity of the peptide–liposome
interaction, we examined the effect of acrylamide, a water-
soluble neutral quencher of Trp fluorescence. Acrylamide is
useful as a quenching agent because it does not interact with the
head group of negatively charged phospholipids. Stern–Volmer
plots for the quenching of Trp by acrylamide, recorded in Tris-
buffer or in the presence of negatively charged or zwitterionic
SUVs, are depicted in Fig. 6, and the Stern–Volmer quenchinglues are the means of two independent experiments performed in triplicate±S.D.
), ME-f (▽), ME-k (▪).
Fig. 6. Stern–Volmer plots for the quenching of Trp fluorescence of 3 μM
peptides by an aqueous quencher, acrylamide, in Tris-HCl buffer (pH 7.4) (A) or
in the presence of 0.6 mM EYPE/EYPG (7:3, w/w) SUVs (B) or 0.6 mM EYPC/
cholesterol (10:1, w/w) SUVs (C). Peptides are indicated as follows: ME (●),
ME-a (○), ME-l (▾), ME-f (▽), ME-k (▪).
Fig. 7. The dose-dependent peptide-induced calcein release from 148 μM
calcein-entrapped negatively charged EYPE/EYPG (7:3, w/w) LUVs. The
percentage of dye-leakage caused by the peptides was calculated as follows: %
Dye-leakage=100×[(F−F0) / (Ft−F0)], where F is the fluorescence intensity
achieved at 5 min after addition of peptides, F0 and Ft are fluorescence
intensities without the peptides and with Triton X-100, respectively. Values are
the means of three independent experiments±S.D. values (error bars). Peptides
are indicated as follows: ME (●), ME-a (○), ME-l (▾), ME-f (▽), ME-k ( ).
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negatively charged phospholipids [EYPE/EYPG (7:3, w/w)
SUVs], the Ksv values of ME-l, ME-f, and ME-k were much
lower than in the presence of zwitterionic phospholipids
[EYPC/cholesterol (10:1, w/w) SUVs], indicating that the Trp
residue of these peptides is less accessible to acrylamide in the
presence of negatively charged SUVs than in the presence of
zwitterionic SUVs (Table 4). The Ksv for ME was the smallest
and, unlike the analogues, essentially the same in the presence
of negatively charged and zwitterionic SUVs, suggesting that its
tryptophan residue was buried in the hydrophobic lipid phase ofthe bilayer in both types of liposome. ME-a had a large Ksv in
both types of liposomes, suggesting that it binds to the surfaces
of both.
Together, the fluorescence data reveal that ME-l, ME-f, and
ME-k have more lipid specificity, whereas ME and ME-a are
not specific for negatively charged and zwitterionic liposomes.
These results correspond well with the results of the biological
activity assays (Table 2, Figs. 4 and 5).
3.11. Calcein leakage from model membranes
To determine whether the antimicrobial activities of peptides
depend on their ability to permeate bacterial membranes, we
measured their abilities to induce calcein leakage from
negatively charged EYPE/EYPG (7:3 w/w) LUVs, which
mimics bacterial membranes. ME was able to cause a complete
leakage of calcein at 0.1μM, a concentrationmuch lower than its
MIC, whereas the peptoid residue-containingME analogues had
little or no activity until 4 μM (Fig. 7). In particular, even at a
peptide concentration as high as 32 μM, the ME analogues had
little or no ability to induce calcein leakage (data not shown).
3.12. Depolarization of the membrane potential in intact
bacteria
We next used a potential depolarization assay to further
examine the ability of the peptides to permeate bacterial
membranes. Peptide-induced membrane permeation caused a
dissipation of the transmembrane potential that monitored by an
increase in fluorescence due to the release of the membrane
potential-sensitive fluorescent dye 3,3′-dipropylthiadicarbocya-
nine iodide (DiSC3-5). We found that ME can completely
depolarize cytoplasmic membrane of intact S. aureus at its MIC
(0.5 μM) (Fig. 8). In contrast, ME-a, ME-l, and ME-k caused
little or no membrane depolarization at their MICs, and caused
till much weaker even at concentrations of 3-fold higher than▪
Fig. 8. Effect of the peptides on the membrane potential of intact S. aureus cells (OD600=0.05). Peptides concentrations are their MIC as follows: ME, 0.5 μM; buforin,
2 μM; ME-a, 16 μM; ME-l, 4 μM; ME-f, 2 μM; ME-k, 2 μM. Experiments were repeated independently three times to ensure reproducibility.
1514 W.L. Zhu et al. / Biochimica et Biophysica Acta 1768 (2007) 1506–1517their MICs (Fig. 9). Noticeably, ME-f caused about 10%
membrane depolarization at its MIC (Fig. 8) and caused a
weaker does-dependent depolarization of the transmembrane
potential than ME (Fig. 9). ME-f was somewhat more effective
than the other three ME analogues, probably due to its higher
hydrophobicity.
3.13. Lipid flip-flop on asymmetrically NBD-labeled model
membrane
It has been reported that membrane-targeting antimicrobial
peptides, such as ME and magainin 2, induce lipid flip-flop inFig. 9. Dose-dependent dissipating of the transmembrane potential of S. aureus
cells (OD600=0.05) by the peptides. The membrane potential-dissipating
activity of the peptides is expressed as follows: % Membrane
depolarization=100×[(Fp−F0) / (Fg−F0)], where F0 is the stable fluorescence
value after addition of the DiSC3-5 dye, Fp is the fluorescence value 5 min after
addition of the peptides, and Fg the fluorescence signal after the addition of
gramicidin D. Values are the means of three independent experiments±S.D.
values (error bars). Peptides are indicated as follows: ME (●), ME-a (○), ME-l
(▾), ME-f (▽), ME-k (▪).NBD-labeled EYPE/EYPG (7:3, w/w) LUVs but that buforin 2
and PR-39, which are non-membrane-targeting peptides (i.e.,
they act on intracellular targets), do not [24,34,35]. Fig. 10
shows the does-dependence of peptide-induced lipid flip-flop in
asymmetrically NBD-labeled EYPE/EYPG (7:3, w/w) LUVs.
As expected, ME caused a significant does-dependent peptide-
induced lipid flip-flop, with 100% lipid flip-flop at 4 μM (Fig.
10). In contrast, none of the peptoid residue-containing ME
analogues induced any detectable lipid flip-flop at 4 μM, as
found for buforin 2 (Fig. 10). Furthermore, the peptoid residue-Fig. 10. Dose-dependent peptide-induced lipid flip-flop in 0.1 mM asymme-
trically NBD-labeled negatively charged EYPE/EYPG (7:3, w/w) LUVs. The
percent flip-flop value was defined by the following equation: % flip-
flop=100×[(F0−Fp) / (F0−Ft)], where F0, Fp, and Ft represent the fluorescence
intensity in asymmetrically labeled liposomes without the peptide, achieved at
5 min after addition of peptides, and with Triton X-100, respectively. Values are
the means of three independent experiments±S.D. values (error bars). Peptides
are indicated as follows: ME (●), ME-a (○), ME-l (▾), ME-f (▽), ME-k (▪),
Buforin 2 (□).
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(data not shown).
4. Discussion
4.1. Relationship between self-association and cell selectivity
of the peptides
Although the peptoid residue-containing ME analogues had
weaker antimicrobial activity than ME (2- to10-fold lower
activity), they exhibited little or no cytotoxicity against human
red blood cells, HeLa and NIH 3T3 cells even at 100 μM. In this
study, we calculated the therapeutic index (MHC-to-MIC ratio),
which is a widely accepted measure of the selectivity of
antimicrobial agents. A larger therapeutic index indicates
greater cell selectivity [10]. Compare to ME, the peptoid
residue-containing ME analogues had much higher therapeutic
indices (23.3- to 119.0-fold higher), indicating that they were
more cell-selective.
Analysis of the interaction of peptides with negatively
charged and zwitterionic model liposome, which mimics
bacterial membranes and mammalian outer membranes,
respectively, revealed that ME-l, ME-f and ME-k are selective
for lipids but that ME is not. This is consistent with their cell
selectivity (i.e., therapeutic indices). Notably, ME-a had 23.3-
fold higher therapeutic index than ME, however ME-a had a
relatively poor selectivity for lipids. This can be explained by
the fact that its increased therapeutic index was more due to a
lower hemolytic activity than a change in antimicrobial activity.
ME is known to cause the lysis of mammalian cells as a
result of pore formation. Briefly, ME initially binds to
mammalian cell membrane by an electrostatic interaction,
after which it adopts an amphipathic α-helical structure, and the
hydrophobic part inserts deeply into the hydrophobic environ-
ment of the membrane. Finally, four monomeric ME molecules
cluster together to form a tetramer through hydrophobic
interactions, creating a transmembrane pore with a barrel-
stave structure that mediates cell lysis [43–45].
It is expected that elimination of ability to form an
amphipathic α-helix would prevent ME from self-associating.
We therefore disrupted the α-helical conformation of ME by
substituting leucine and isoleucine in the Leu zipper sequence
with peptoid residues. Specifically, we observed a random
structure in zwitterionic EYPC/cholesterol (10:1, w/w) SUVs,
which mimic mammalian outer membranes. Furthermore, CD
spectrum and trytophan fluorescence studies revealed that the
peptoid residue-containing ME analogues cannot self-associate
into oligomers in aqueous conditions at high ionic strength. This
supports the idea that the disruption of an amphipathic α-helical
conformation prevents ME from self-associating into an
oligomer. This disruption of the amphipathic α-helical structure
in zwitterionic membranes and self-association activity prevents
the formation of transmembrane pores by the peptoid residue-
containing analogues. As a result, the analogues were unable to
cause hemolysis.
In contrast, disruption of the ability to form an amphipathic
α-helical structure in negatively charged EYPE/EYPG (7:3, w/w) SUVs and self-associate had no effect on antimicrobial
activity, which is thought to be consistent with the hydro-
phobicity and cationicity of the peptides. Excluding ME-k, the
order of antimicrobial activity of the peptides was ME>ME-
f>ME-l>ME-a, which is also in agreement with their
hydrophobicity. ME-k, which was the most cationic (+9), had
the same ability to kill bacteria as ME-f, although its
hydrophobicity was the lowest. Therefore, there may be a
threshold or balance between hydrophobicity and cationicity
that controls the antimicrobial activity of the peptides.
Taken together, our results indicate that disrupting the ability
of ME to self-associate by replacement of heptadic leucine/
isoleucine residues with peptoid residues eliminates their
toxicity to mammalian cells. In contrast, the ability of the
peptides to self-associate does not appear to be related to their
antimicrobial activity.
4.2. Possible mode of antibacterial action
Bacterial membrane permeabilization/disruption is thought
to be a general mechanism by which membrane-active
antimicrobial peptides kill bacteria. ME, one of the most
studied membrane-targeting antimicrobial peptides, appears to
permeate bacteria membranes by a carpet-like mechanism [45–
47], and it can completely disrupt bacterial membranes at a
much lower concentration than its MIC. In contrast to
membrane-targeting antimicrobial peptides, some antimicrobial
peptides may target non-membrane intracellular components
and cause bacterial cell death by inhibiting or terminating
protein, DNA or RNA synthesis [48,49]. For example, buforin 2
discovered in the stomach tissue of the Asian toad Bufo bufo
gargarizans, can penetrate cells without inducing severe
membrane permeabilization. This peptide inhibits cellular
functions and results in rapid cell death by binding to DNA
and RNA [50–52].
Our results indicated that ME can completely disrupt model
and intact bacterial membranes at concentrations below 0.2 μM
and that it induces complete lipid flip-flop in model membranes
at 4 μM. The peptoid residue-containing ME analogues had
weaker or no abilities to cause membrane permeabilization/
disruption and lipid flip-flop, similar to buforin 2. These results
suggest that, like buforin 2, the peptides probably primarily act
by targeting intracellular components rather than the bacterial
membrane. Thus, substitution of the leucine zipper sequence
with peptoid residues converted ME from a membrane-targeting
mechanism to a possible intracellular mechanism.
Notably, ME-f caused about 10% membrane depolarization
at its MIC and was less potent than ME at depolarizing the
bacterial membrane, indicating that a membrane-targeting
mechanism cannot be completely excluded for this analogue.
This ability of ME-f to cause some depolarization is likely due
to its relatively high hydrophobicity. Additionally, although
ME-f causes partially membrane depolarization, it did not
induce calcein leakage even at 32 μM. The most likely
explanation for this result is that ME-f forms some small
channels in the membrane that permit the leakage of ions or
protons but not larger molecules like calcein [53].
1516 W.L. Zhu et al. / Biochimica et Biophysica Acta 1768 (2007) 1506–1517In conclusion, our results demonstrated that substitution of
amino acids in the leucine zipper sequence of ME with
peptoid residues increases the selectivity of ME for bacterial
cells by impairing its self-association ability and changes the
mode of antibacterial action from membrane-targeting
mechanism to possible intracellular targeting mechanism.
We believe that the findings presented in this report will be
useful for converting α-helical non-cell-selective antimicro-
bial peptides that self-associate and are highly toxic to
mammalian cells into new antimicrobial peptides with
enhanced cell selectivity and a possible intracellular
mechanism.
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